Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature.

VAP ceftazidime/avibactam non-fermenter gram negative

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
26 Jul 2022
Historique:
received: 27 06 2022
revised: 22 07 2022
accepted: 22 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Ventilator-associated pneumonia (VAP) in critically ill patients with COVID-19 represents a very huge global threat due to a higher incidence rate compared to non-COVID-19 patients and almost 50% of the 30-day mortality rate.

Identifiants

pubmed: 35892396
pii: antibiotics11081007
doi: 10.3390/antibiotics11081007
pmc: PMC9330655
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

J Glob Antimicrob Resist. 2018 Dec;15:136-139
pubmed: 30036695
Med Mal Infect. 2020 May;50(3):305-307
pubmed: 32014291
Antibiotics (Basel). 2021 May 07;10(5):
pubmed: 34067186
Open Forum Infect Dis. 2019 Dec 06;6(12):ofz522
pubmed: 31890725
Crit Care. 2021 Jan 11;25(1):25
pubmed: 33430915
Int J Antimicrob Agents. 2017 May;49(5):579-588
pubmed: 28363526
J Clin Med. 2020 Jan 19;9(1):
pubmed: 31963877
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2849-57
pubmed: 26926635
Int J Antimicrob Agents. 2015 Jul;46(1):53-9
pubmed: 25956844
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
Lancet Infect Dis. 2018 Mar;18(3):285-295
pubmed: 29254862
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502
pubmed: 33389263
Curr Opin Infect Dis. 2021 Dec 1;34(6):737-747
pubmed: 34261906
BMC Microbiol. 2022 May 12;22(1):129
pubmed: 35549675
J Antimicrob Chemother. 2018 Sep 1;73(9):2519-2523
pubmed: 29912399
Int J Antimicrob Agents. 2010 Feb;35(2):194-9
pubmed: 20006471
J Cyst Fibros. 2004 Jun;3(2):93-8
pubmed: 15463892
Diagn Microbiol Infect Dis. 2020 Mar;96(3):114833
pubmed: 31924426
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29588357
Intensive Care Med. 2022 Apr;48(4):514-515
pubmed: 34817634
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28827415
J Antimicrob Chemother. 2019 Dec 1;74(12):3497-3504
pubmed: 31504587
Chest. 2021 Aug;160(2):454-465
pubmed: 33857475
ACS Infect Dis. 2017 Jul 14;3(7):502-511
pubmed: 28264560
Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):901-6
pubmed: 18483755
Clin Microbiol Infect. 2022 Apr;28(4):521-547
pubmed: 34923128
Intensive Care Med. 2018 Dec;44(12):2216-2218
pubmed: 29797028
Antibiotics (Basel). 2022 Apr 19;11(5):
pubmed: 35625189
BMC Microbiol. 2021 Feb 22;21(1):60
pubmed: 33618662
Antibiotics (Basel). 2022 Apr 20;11(5):
pubmed: 35625190
Clin Microbiol Infect. 2022 Apr;28(4):465-469
pubmed: 35150882
Ther Drug Monit. 2021 Apr 1;43(2):146-149
pubmed: 33315762
Clin Infect Dis. 2018 Apr 3;66(8):1204-1210
pubmed: 29126110
J Infect Dis. 2019 Jul 19;220(4):666-676
pubmed: 31099835
Crit Care. 2020 Jun 29;24(1):383
pubmed: 32600375
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29507064
J Glob Antimicrob Resist. 2021 Sep;26:15-19
pubmed: 33989847
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114
pubmed: 34864936
Antimicrob Agents Chemother. 1997 Sep;41(9):2013-5
pubmed: 9303404
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3163-9
pubmed: 26926648
J Clin Med. 2020 Nov 24;9(12):
pubmed: 33255354
Cochrane Database Syst Rev. 2020 Apr 2;4:CD009529
pubmed: 32239690
Lancet Infect Dis. 2016 Jun;16(6):661-673
pubmed: 27107460
Clin Infect Dis. 2022 Apr 19;:
pubmed: 35439291
Antibiotics (Basel). 2021 Sep 18;10(9):
pubmed: 34572708
Infect Control Hosp Epidemiol. 2022 May 20;:1-5
pubmed: 35591782
Clin Microbiol Rev. 1998 Jan;11(1):57-80
pubmed: 9457429
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28993338
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4490-500
pubmed: 27161636
Future Microbiol. 2009 Nov;4(9):1103-9
pubmed: 19895214
Clin Chest Med. 2018 Dec;39(4):837-852
pubmed: 30390753
Microb Drug Resist. 2022 May;28(5):545-550
pubmed: 35512733
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4743-9
pubmed: 27216074
Clin Infect Dis. 2018 Nov 28;67(12):1803-1814
pubmed: 30052813
J Antimicrob Chemother. 2021 Feb 11;76(3):775-783
pubmed: 33249436
PLoS One. 2021 Feb 11;16(2):e0246318
pubmed: 33571301
Antibiotics (Basel). 2021 Aug 20;10(8):
pubmed: 34439062
Antibiotics (Basel). 2021 Oct 08;10(10):
pubmed: 34680805
Drugs R D. 2018 Sep;18(3):221-230
pubmed: 30054895
BMJ Open. 2022 Jan 3;12(1):e054069
pubmed: 34980623
Infect Control Hosp Epidemiol. 2021 Apr 19;:1-3
pubmed: 33866991
Clin Infect Dis. 2016 Jun 1;62(11):1380-1389
pubmed: 26962078
Antibiotics (Basel). 2021 Nov 22;10(11):
pubmed: 34827363
J Clin Med. 2021 Feb 03;10(4):
pubmed: 33546093
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31818820
J Antimicrob Chemother. 2015 Oct;70(10):2862-9
pubmed: 26133566
J Cyst Fibros. 2021 May;20(3):e29-e31
pubmed: 33883098
Infect Dis (Lond). 2016 Oct;48(10):738-43
pubmed: 27207483
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384
Semin Respir Crit Care Med. 2022 Apr;43(2):280-294
pubmed: 35088403
J Antimicrob Chemother. 2019 May 1;74(5):1425-1429
pubmed: 30649419

Auteurs

Giulia Jole Burastero (GJ)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Gabriella Orlando (G)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Antonella Santoro (A)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Marianna Menozzi (M)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Erica Franceschini (E)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Andrea Bedini (A)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Adriana Cervo (A)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Matteo Faltoni (M)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Erica Bacca (E)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Emanuela Biagioni (E)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Irene Coloretti (I)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Gabriele Melegari (G)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Jessica Maccieri (J)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Stefano Busani (S)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Elisabetta Bertellini (E)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Massimo Girardis (M)

Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Giulia Ferrarini (G)

Clinical Microbiology Unit, AUSL, Modena, Via Giardini 1355, 41126 Baggiovara, Italy.

Laura Rofrano (L)

Clinical Microbiology Unit, AUSL, Modena, Via Giardini 1355, 41126 Baggiovara, Italy.

Mario Sarti (M)

Clinical Microbiology Laboratory, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Cristina Mussini (C)

Clinic of Infectious Diseases, Department of Infectious Diseases, University of Modena, 41124 Modena, Italy.

Marianna Meschiari (M)

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Classifications MeSH